COVID-19 in the Cancer Patient
Cindy Yeoh, Kathleen J. Lee, Elizabeth F. Rieth, Renee Mapes, Anna V. Tchoudovskaia, Gregory W. Fischer, Luis Tollinche
Abstract
The novel coronavirus disease 2019 (COVID-19) was first reported in China in December 2019. Since then, it has spread across the world to become one of the most serious life-threatening pandemics since the influenza pandemic of 1918. This review article will focus on the specific risks and nuanced considerations of COVID-19 in the cancer patient. Important perioperative management recommendations during this outbreak are emphasized, in addition to discussion of current treatment techniques and strategies available in the battle against COVID-19.
Topics & Concepts
MedicinePandemicCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)OutbreakBattleIntensive care medicineCoronavirusDiseaseBetacoronavirusInfectious disease (medical specialty)VirologyPathologyArchaeologyHistoryCOVID-19 and healthcare impactsCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19